Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Psychiatry|July 1, 1983
Onset of action of amoxapine and doxepin in outpatients with "mixed anxiety/depression"L J Hekimian, C C Weise, A J FriedhoffJournal of Child and Adolescent Psychopharmacology|July 28, 2009
Persistent Tardive Dyskinesia and Other Neuroleptic-Related Dyskinesias in Tourette's DisorderR R Silva, H J Magee, A J FriedhoffLife Sciences|January 1, 1989
Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patientsR Davila, M Zumarraga, I Andia, et al.The Journal of Biological Chemistry|December 25, 1992
Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysisJ Wu, D Filer, A J Friedhoff, et al.Research Communications in Chemical Pathology and Pharmacology|September 1, 1982
Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortexE Meller, K Bohmaker, H Rosengarten, et al.Life Sciences|January 1, 1990
The effect of hyperthyroidism on opiate receptor binding and pain sensitivityE A Edmondson, K A Bonnet, A J FriedhoffThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1985
Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neurolepticsE Meller, K Bohmaker, M Goldstein, et al.Archives of Neurology|October 1, 1977
Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapyM A Pollack, N L Cohen, A J FriedhoffLife Sciences|May 13, 1985
Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonistE Meller, S Kuga, A J Friedhoff, et al.The American Journal of Psychiatry|November 1, 1978
Paradoxical reaction to L-dopa in schizophrenic patientsM Alpert, A J Friedhoff, L R Marcos, et al.Pageof 7